Treatment with anti-amyloid β antibodies is becoming standard therapy for early Alzheimer's disease, as lecanemab and donanemab received full approval in the USA, Japan, and other countries between ...

There's still more than two months until the 2026 Maryland General Assembly kicks off, but on Tuesday, local officials struck ...

New AI agent delivers quotes up to three times faster, doubles call-to-bind conversion, and gives producers more time to ...